DHA Supportive Comments on the Regulation of Kratom (HS 1 for HB 332)

Frame-Shape

DHA shared a letter of support with Senator Marie Pinkney regarding House Substitute 1 for House Bill 332, which would increase transparency in the marketing and selling of kratom and prohibits the sale of the product to individuals under the age of 21.

Click here to read the letter. 

Related Links

divider-shape

Comments – Request for Information: 340B Rebate Model Pilot Program, HHS Docket No. HRSA-2026-03042

Comments on CMS Proposed Payment Rule for Home Health Agencies

No results found.